We collect cookies to analyze our website traffic and performance; we never collect any personal data. Cookie Policy
Accept
NEW YORK DAWN™NEW YORK DAWN™NEW YORK DAWN™
Notification Show More
Font ResizerAa
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Reading: Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Share
Font ResizerAa
NEW YORK DAWN™NEW YORK DAWN™
Search
  • Home
  • Trending
  • New York
  • World
  • Politics
  • Business
    • Business
    • Economy
    • Real Estate
  • Crypto & NFTs
  • Tech
  • Lifestyle
    • Lifestyle
    • Food
    • Travel
    • Fashion
    • Art
  • Health
  • Sports
  • Entertainment
Follow US
NEW YORK DAWN™ > Blog > Health > Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy
Health

Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy

Last updated: January 28, 2025 1:19 pm
Editorial Board Published January 28, 2025
Share
SHARE

A photograph of Natsumeda lab members, together with Dr. Satoshi Shibuma (far left) and Dr. Manabu Natsumeda (far proper). Credit score: Niigata College

A bunch led by the Division of Neurosurgery, Mind Analysis Institute, Niigata College, has succeeded within the prognosis of leptomeningeal illness in diffuse midline gliomas by detecting H3K27M-mutant droplets from circulating tumor DNA of cerebrospinal fluid taken from these sufferers.

The work is printed within the journal Pediatric Blood & Most cancers on January 9, 2025.

In two sufferers, leptomeningeal illness was identified sooner than with conventional strategies reminiscent of MRI and cerebrospinal fluid cytology. In a single affected person, long run survival after the prognosis of leptomeningeal illness by early and aggressive intervention together with surgical procedure, radiation, and intrathecal supply of chemotherapeutic brokers led to long run survival.

A group led by Dr. Manabu Natsumeda used droplet digital PCR, a extremely delicate PCR system, to detect hint quantities of circulating tumor DNA from the cerebrospinal fluid of those sufferers.

“We found that detecting circulating tumor DNA in the cerebrospinal fluid of diffuse midline glioma patients was more difficult than other brain tumor patients such as primary central nervous system lymphoma and glioblastoma,” explains Dr. Natsumeda.

“However, when we were able to detect mutant tumor DNA, often the tumor had already spread to the cerebrospinal fluid, causing leptomeningeal disease. We think that early diagnosis and treatment of leptomeningeal disease in diffuse midline gliomas can improve survival.”

Extra info:
Satoshi Shibuma et al, Analysis of Leptomeningeal Illness in Diffuse Midline Gliomas by Detection of H3F3A K27M Mutation in Circulating Tumor DNA of Cerebrospinal Fluid, Pediatric Blood & Most cancers (2025). DOI: 10.1002/pbc.31535

Offered by
Niigata College

Quotation:
Research succeeds in early prognosis of leptomeningeal illness in diffuse midline gliomas by liquid biopsy (2025, January 27)
retrieved 28 January 2025
from https://medicalxpress.com/information/2025-01-succeeds-early-diagnosis-leptomeningeal-disease.html

This doc is topic to copyright. Aside from any honest dealing for the aim of personal research or analysis, no
half could also be reproduced with out the written permission. The content material is supplied for info functions solely.

You Might Also Like

Psilocybin may reverse results of mind accidents ensuing from intimate associate violence, rat research finds

Predicting illness outbreaks utilizing social media

Deep mind stimulation succeeds for 1 in 2 sufferers with treatment-resistant extreme melancholy and nervousness in trial

Australian drug driving deaths have surpassed drunk driving. Here is the way to deal with it

Tooth of infants of confused moms come out earlier, suggests examine

TAGGED:biopsydiagnosisdiffusediseaseEarlygliomasleptomeningealLiquidmidlinestudysucceeds
Share This Article
Facebook Twitter Email Print

Follow US

Find US on Social Medias
FacebookLike
TwitterFollow
YoutubeSubscribe
TelegramFollow
Popular News
Netflix helped convey F1 to new heights. Now the game is poised to return the favor
Entertainment

Netflix helped convey F1 to new heights. Now the game is poised to return the favor

Editorial Board November 29, 2024
Rep. Nydia Velazquez gained’t search reelection to deep-blue Home seat
Unio goals greater in Web3 gaming with new CEO Mark Lengthy
Former Baltimore Orioles pitcher Brian Matusz dies at 37
Biden appeared ‘catatonic,’ didn’t acknowledge Clooney earlier than ending marketing campaign

You Might Also Like

New malaria drug heralds resistance breakthrough
Health

New malaria drug heralds resistance breakthrough

November 18, 2025
Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain
Health

Chasing a successful streak: A brand new approach to set off responses within the physique by simulating psychological strain

November 18, 2025
The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years
Health

The worldwide system for assessing organ dysfunction in critically sick sufferers is up to date after thirty years

November 18, 2025
Breast most cancers remedies can enhance each survival probabilities and revenue
Health

Breast most cancers remedies can enhance each survival probabilities and revenue

November 18, 2025

Categories

  • Health
  • Sports
  • Politics
  • Entertainment
  • Technology
  • Art
  • World

About US

New York Dawn is a proud and integral publication of the Enspirers News Group, embodying the values of journalistic integrity and excellence.
Company
  • About Us
  • Newsroom Policies & Standards
  • Diversity & Inclusion
  • Careers
  • Media & Community Relations
  • Accessibility Statement
Contact Us
  • Contact Us
  • Contact Customer Care
  • Advertise
  • Licensing & Syndication
  • Request a Correction
  • Contact the Newsroom
  • Send a News Tip
  • Report a Vulnerability
Term of Use
  • Digital Products Terms of Sale
  • Terms of Service
  • Privacy Policy
  • Cookie Settings
  • Submissions & Discussion Policy
  • RSS Terms of Service
  • Ad Choices
© 2024 New York Dawn. All Rights Reserved.
Welcome Back!

Sign in to your account

Lost your password?